Factory Construction to Begin in H1 Next Year; Targeting 3 Trillion KRW in Revenue by 2031
Celltrion Launches CDMO Subsidiary ‘BioSolutions’
Celltrion has established a new subsidiary specializing in contract development and manufacturing organization (CDMO) services, offering comprehensive solutions from drug development to…